The Hopeful Convergence of Indigenous Rights and Modern Industry
Ricardo Baca, Grasslands
Julia Mande, A2C / Common Field
Who Is Today’s Psychedelic Consumer? A Deep Dive into Data and Trends
Amanda Reiman, New Frontier Data / Personal Plants
Bethany Gomez, Brightfield Group
Philippe Lucas, SABI Mind
Policy Updates and Forecasts: State-Level Initiatives and FDA Approval Pipelines
Josh Hardman, Psychedelic Alpha
Sam Chapman, Healing Advocacy Fund
Courtney Barnes, Feldman Legal Advisors
Decrim, Gifting and Gray Markets: What Every Business Owner Needs to Know
Amanda Reiman, New Frontier Data / Personal Plants
Graham Pechenik, Calyx Law
Ricardo Baca, Grasslands
Workplace Safety & Risk Reduction for Psychedelic Businesses
Erica Siegal, NEST Harm Reduction & Consulting
The For-Profit Psychedelic Business Model: How to Be Ethical, Sustainable and Profitable
Sean McAllister, McAllister Law Office
Ariel Clark, Clark Howell LLP
Scarlet Masius, Tactogen
The Power of Nonprofits: The Story of Alchemy Community Therapy Center
Deidra Somerville, Former Executive Director
Keynote: From Adversity to Emergence: A Journey of Transformation and Purpose
Raad Seraj, Mission Club
Creative Fundraising & Investing: How to Find the Right Partners to Fund Your Venture
Scarlet Masius, Tactogen
Rebecca Nicholson, 5D Ventures
Raad Seraj, Mission Club
Functionals, Microdosing, and Brain Health: The Latest Research and Trends
Chris Claussen, First Person
Courtney Barnes, Feldman Legal Advisors
Paul F. Austin, Third Wave & Psychedelic Coaching Institute
Meet the Entrepreneur: The Visionary Behind Mojo Microdose
Stefany Nieto, Gwella / Mojo Microdose
Mushroom Testing: Psilocybin and Beyond
Daniel Riddle, Panacea Life Sciences
Daniel Huson, Rose City Laboratories
Rocco Iannapollo, 710SCI
Expansion of Access: How to Make Psychedelics Treatments Affordable for All
Joe Moore, Psychedelics Today
Veronica Lightning Horse Perez, Medicine Woman
Sherry Rais, Enthea
Ketamine Clinics: A Road Map from Concept to Profitability
Josh Hardman, Psychedelic Alpha
Nykol Bailey Rice, Boise Ketamine Clinic
Chris Walden, Ketamine Media
Psychedelic Retreats and Wellness Centers: Insider Strategies for Success
Joe Moore, Psychedelics Today
Frederica Helmiere, The Synthesis Institute
Ryan Reid, Bendable Therapy
Set Up Your Business for Success: Insider Advice on Taxes, Banking, Contracts and More
Britt Rollins, National Psychedelics Association
Nicole Howell, Psychedelic Bar Association
Justin Botillier, Calyx CPA LLC
Breaking Down the First Draft Rules for Psychedelics in Colorado
Josh Hardman, Psychedelic Alpha
Tasia Poinsatte, Healing Advocacy Fund
Josha Kappel, Vincente LLP
Psychedelics Education & Training: What Operators & Educators Need to Know
Hosted in partnership with Neuly
Joe Moore, Psychedelics Today
Dana Lerman, Skylight Psychedelics
Ingmar Gorman, Fluence
Sonia Stringer
5 Things the Cannabis Industry Should Know About Psychedelics
Hosted in partnership with MJBiz
Bethany Gomez, Brightfield Group
Chris Claussen, First Person
Courtney Barnes, Feldman Legal Advisors
How to Run a Successful Psychedelic Clinic: Insights & Advice for Operators and Entrepreneurs
Kim Turpin, Pearl Psychedelic Institute
Nykol Rice, Boise Ketamine Clinic
Chris Walden, Ketamine Media
The Psychedelic Business Landscape in Oregon and Colorado
Sheva Pekar, PsyCann Advisors
Sean McAllister, McAllister Law Office
Perry Salzhauer, Green Light Law Group
The New Psychedelics Era: Politics, Profit & Principles
Ethan Nadelmann, Host, Psychoactive Podcast
One Veteran’s Personal Journey with Psychedelics and PTSD
Neil Markey, CEO & Co-Founder, Beckley Retreats
Cannabis & Psychedelics – Similar Story, Different Trajectory
Simeon Schnapper, Managing Partner, JLS Fund
Scarlet Masius, Head of Community, Tactogen
Michael Huttner, CEO & Co-Founder, Next Titan Capital
Jeff Zuber, Founding Partner, Zuber Lawler
Capitalism & Consciousness: The Evolution of Business
Dustin Robinson, Managing Principal, Iter Investments
Troy Sia, Co-Founder , Sia the Piah Puha Kahni “Mother Church”
Liana Gillooly, Strategic Initiatives Officer, MAPS
Amanda Reiman, Chief Knowledge Officer at New Frontier Data, Founder at Personal Plants
How the Psychedelics Marketplace Will Evolve: Part 2
Bethany Gomez, Managing Director, Brightfield Group
How the Psychedelics Marketplace Will Evolve: Part 1
Ariel Clark, Principal, Clark Howell LLP
Changing Lives: The Promise of Psychedelics
Lynn Marie Morski, President, Psychedelic Medicine Association
Investing in Psychedelics
Simeon Schnapper, Managing Partner, JLS Fund
Scarlet Masius, Head of Community, Tactogen
Michael Huttner, CEO & Co-Founder, Next Titan Capital
Jeff Zuber, Founding Partner, Zuber Lawler
Psychedelic Drug Discovery
Jackie Von Salm, Co-Founder & Chief Scientific Officer, Psilera
Benjamin Lightburn, CEO & Co-Founder, Filament Health
The Future of Psychedelics: Entrepreneurial Perspectives
Todd Shapiro, CEO, JLS Fund
Sutton King, Program Manager Indigenous Medicine, Conservation Fund
Chris Claussen, Chief Innovation Officer, First Person Group
Kelsey Ramsden, Advisory Board, reMind
Ronan Levy, Chairman & CEO, Field Trip Health
